EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance

Rajnikant Sharma iD, Ramya Mahadevan, Sai Divyash, Shekhar Yeshwante, Saikumar Matcha, ChunFu Cheng, Hunter S Talley, Alan A Schmalstig, Pradeep Neupane, Sara E Maloney Norcross iD, Anthony J Hickey, Graham F Hatfull und 2 weitere

Molecular Pharmaceutics · 05.10.2026 · 23 (10) · 4998-5011

DOI: 10.1021/acs.molpharmaceut.6c00604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 17.09.2026. Verfasst von Rajnikant Sharma und 13 weiteren Autor:innen. Beteiligte Einrichtung: USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California90033, United States. Hauptthemen laut MEDLINE: Mycobacteriophages, Lung, Phage Therapy. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Emily's Entourage, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophage therapy is being explored as an alternate therapeutic approach for treating drug-resistant bacteria, including mycobacteria. However, rational phage dosing remains limited by scarce pharmacokinetic (PK) data and an incomplete understanding of tissue distribution. We performed dose-ranging studies in mice of three therapeutic mycobacteriophages (BPsΔ, ZoeJΔ, Muddy) after intravenous (IV) and intratracheal (IT) administration. All phages behaved similarly. IV dosing produced biphasic kinetics with nonproportional exposure and declining tissue-to-plasma ratios, indicating saturable uptake and elimination. IT delivery yielded monophasic profiles with ∼390-fold higher lung exposure and ∼490-fold lower plasma exposure, supporting inhaled therapy for pulmonary mycobacterial infections. Using BPsΔ data, we developed a mechanistic PBPK model incorporating transcytosis, saturable host clearance, plasma elimination, and lymphatic transport. The model accurately predicted ZoeJΔ and Muddy PK, enabled cross-species extrapolation, and showed that phage morphology influences disposition. This framework advances phage therapy toward model-informed, exposure-guided dose and route selection for multidrug-resistant bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycobacteriophagesLungPhage TherapyAnimalsMiceTissue DistributionModels, BiologicalFemale

Stichwörter der Autor:innen

PBPK modelintratrachealintravenousmycobacteriophagepharmacokinetics

Autor:innen und Institutionen

  • USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California90033, United States.
  • Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, United States.
  • Department of Microbiology & Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, United States.
  • Engineering and Advanced Technology Department, RTI International, Durham, North Carolina27713, United States.
  • Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania15260, United States.
  • Mycobacteria Research Laboratories, Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, Colorado80202, United States.

ORCID-Profile: Rajnikant Sharma, Sara E Maloney Norcross, Gauri G Rao

Förderung

  • NIGMS NIH HHS
  • Emily's Entourage
  • NHLBI NIH HHS
  • Cystic Fibrosis Foundation
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Howard Hughes Medical Institute
  • NIDDK NIH HHS

Zitieren

APA

Sharma, R., Mahadevan, R., Divyash, S., Yeshwante, S., Matcha, S., Cheng, C., Talley, H. S., Schmalstig, A. A., Neupane, P., Maloney Norcross, S. E., Hickey, A. J., Hatfull, G. F., Braunstein, M., & Rao, G. G. (2026). Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance. Molecular Pharmaceutics, 23(10), 4998-5011. https://doi.org/10.1021/acs.molpharmaceut.6c00604

Vancouver

Sharma R, Mahadevan R, Divyash S, Yeshwante S, Matcha S, Cheng C, et al. Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance. Molecular Pharmaceutics. 2026;23(10):4998-5011. doi:10.1021/acs.molpharmaceut.6c00604

BibTeX
@article{Sharma2026,
  author = {Sharma, Rajnikant and Mahadevan, Ramya and Divyash, Sai and Yeshwante, Shekhar and Matcha, Saikumar and Cheng, ChunFu and Talley, Hunter S and Schmalstig, Alan A and Neupane, Pradeep and Maloney Norcross, Sara E and Hickey, Anthony J and Hatfull, Graham F and Braunstein, Miriam and Rao, Gauri G},
  title = {Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Mycobacteriophages: Insights into Pulmonary Distribution and Clearance},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {10},
  pages = {4998--5011},
  doi = {10.1021/acs.molpharmaceut.6c00604}
}
Kostenlos starten →